日本大学医学部 病態病理学系 形態機能病理学分野

Engish

2017

  1. Yamaguchi H, Kuroda K, Sugitani M, Takayama T, Hasegawa K, Esumi M. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles. International Journal of Oncology  DOI:10.3892/ijo.2017.3917
  2. Sunagawa K, Sugitani M. Post-mortem detection of bacteremia using pairs of blood culture samples 24: 92-97, 2017
  3. Sunagawa K, Sakagiami M, Sakagami H, Furuichi M, Kusumi Y, Nakamura S, Miyazaki Y, Sugitani M. A pneumonectomized case of cunninghamella bertholletiae infection detected by the polymerase chain reaction. International Journal of Clinical and Experimental Pathology 10(2): 2219-2223, 2017
  4. Abe H, Midorikawa Y, Mitsuka Y, Aramaki O, Higaki T, Matsumoto N, Moriyama M, Haradome H, Abe O, Sugitani M, Tsuji S, Takayama T. Predicting postoperative outcomes of liver resection by magnetic resonance elastography. Surgery. 2017 Aug;162(2):248-255. doi: 10.1016/j.surg.2017.02.014. Epub 2017 Apr 13.
  5. Haradome H, Unno T, Morisaka H, Toda Y, Kwee TC, Kondo H, Sano K, Ichikawa T, Kondo F, Sugitani M, Takayama T. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations. Eur Radiol. 2017 Apr 24. doi: 10.1007/s00330-017-4811-2. [Epub ahead of print]

つづきを見る

2016

  1. Nakayama Y, Yamaguchi H, Einaga N, Esumi M. Pitfalls of DNA quantification using DNA-binding fluorescent dyes and suggested solutions. PLOS ONE 11(3): e0150528, 2016
  2. Kurokawa T, Yamazaki S, Mitsuka Y, Moriguchi M, Sugitani M, Takayama T. Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin. Br J Cancer 114(1): 53-58, 2016
  3. Numaguchi S, Esumi M, Sakamoto M, Endo M, Ebihara T, Soma H, Yoshida A, Tokuhashi Y. Passive cigarette smoking changes the circadian rhythm of clock genes in rat intervertebral discs. J Orthop Res 34(1): 39-47, 2016
  4. Homma T, Seki T, Suzuki A, Ohta T, Maebayashi T, Yoshino A, Kusumi Y, Sugitani M. Cytopathological features of pilomyxoid astrocytoma: a case report. Cytopathology. 2016 Mar 28. doi: 10.1111/cyt.12336. [Epub ahead of print]
  5. Amano Y, Ohni S, Homma T, Yamada T, Sugitani M, Shiraiwa H, Kitamura N, Takei M. First autopsy case report of Familial Mediterranean fever in a Japanese man. Pathol Int 66(6): 351-353, 2016

つづきを見る

2015

  1. Esumi M, Ishibashi M, Yamaguchi H, Nakajima S, Tai Y, Kikuta S, Sugitani M, Takayama T, Tahara M, Takeda M, and Wakita T. Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection. Hepatology 61(2): 437-446, 2015
  2. Fuchinoue F, Hirotani Y, Nakanishi Y, Yamaguchi H, Nishimaki H, Noda H, Tang XY, Iizuka M, Amano S, Sugitani M, Nemoto N, Masuda S. Overexpression of PGC1α and accumulation of p62 in apocrine carcinoma of the breast. Pathol Int 65(1): 19-26, 2015
  3. Kurita D, Miura K, Nakagawa M, Ohtake S, Sakagami M, Uchino Y, Takahashi H, Kiso S, Hojo A, Kodaira H, Yagi M, Hirabayashi Y, Kobayashi Y, Iriyama N, Kobayashi S, Hatta Y, Kura Y, Sugitani M, Takei M. Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma. Int J Hematol 101(6): 585-593, 2015
  4. Maebayashi T, Abe K, Aizawa T, Sakaguchi M, Ishibashi N, Abe O, Takayama T, Nakayama H, Matsuoka S, Nirei K, Nakamura H, Ogawa M, Sugitani M. Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review. World J Gastroenterol 21(17): 5432–5441, 2015
  5. Watanabe Y, Matsumoto N, Ogawa M, Moriyama M, Sugitani M. Sarcomatoid hepatocellular carcinoma with spontaneous intraperitoneal bleeding. Intern Med, 54(13):1613-1617, 2015

つづきを見る

2014

  1. Ishibashi M, Morita N, Nomura-Kawaguchi C, Shimizu Y, Wakita T, Esumi M. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection. Arch Virol 159(11): 2949-2955, 2014
  2. Kobayashi Y, Hatta Y, Sugitani M, Hojo A, Nakagawa M, Kusuda M, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Miura K, Iriyama N, Kobayashi S, Kura Y, Horikoshi A, Sawada U, Takeuchi J, Takei M. Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55(11): 2514-2519, 2014
  3. Shizukuishi T, Abe O, Haradome H, Fukushima T, Katayama Y, Sugitani M. Granular cell tumor of the neurohypophysis with optic tract edema. Jpn J Radiol 32(3): 179-82, 2014
  4. Takagi K, Takayama T, Moriguchi M, Hasegawa H, Niide O, Kanamori N, Higaki T, Sugitani M. Gastrointestinal: case of accidentally discovered splenic epidermoid cyst with serum CA19-9 elevation. J Gastroenterol Hepatol 29(2): 231, 2014
  5. Watanabe Y, Nakanishi Y, Kinukawa N, Ohni S, Obana Y, Nakazawa A, Nemoto N. Expressions of somatostatin receptor subtypes (SSTR-1, 2, 3, 4 and 5) in neuroblastic tumors; special reference to clinicopathological correlations with international neuroblastoma pathology classification and outcomes. Acta Histochem Cytochem 47(5): 219-229, 2014

つづきを見る

2013

  1. Sunagawa K, Omagari D, Nishiyama M, Asano M, Okudera M, Sugitani M, Nemoto N, Komiyama K. Distinct functional regions of the human polymeric immunoglobulin receptor. Scand J Immunol 78(4) :339-344, 2013.
  2. Yamaguchi H, Matsumoto S, Ishibashi M, Hasegawa K, Sugitani M, Takayama T, and Esumi M. β-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological livers. Exp Mol Pathol 95(2): 131-135, 2013
  3. Yamaguchi H, Hasegawa K, and Esumi M. Protein from the fraction remainingafter RNA extraction is useful for proteomics but care must be exercised in its application. Exp Mol Pathol 95(1): 46-50, 2013
  4. Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, Kawase M, Noda M, Kimura H, Matsuyama S, Fukuhara H, Mizuta K, Maenaka K, Ami Y, Esumi M, Kato A, and Takeda M. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol 87(21): 11930-11935, 2013
  5. Sunagawa K, Ishige T, Kusumi Y, Asano M, Nishikawa E, Kato M, Yagasaki H, Nemoto N. Renal abscess involving mucormycosis by immunohistochemical detection in a patient with acute lymphocytic leukemia: a case report and literature review. Jpn J Inf Dis 66(4): 345-347, 2013

つづきを見る

2012

  1. Asakawa T, Esumi M, Endo S, Kida A, Ikeda M. A mutation at IVS1+5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer? BMC Medical Genetics 13:23, 2012
  2. Taniguchi S, Ryu J, Seki M, Sumino T, Tokuhashi Y, Esumi M. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J Orthop Res 30(5): 673-678, 2012
  3. Hirai R, Makiyama K, Higuti Y, Ikeda A, Miura M, Hasegawa H, Kinukawa N, Ikeda M. Pharyngeal squamous cell papilloma in adult Japanease: comparison with laryngeal papilloma in clinical manifstations and HPV infection. Eur Arch Otorhinol 269: 2271-2276, 2012.
  4. Yamazaki S, Takayama T, Moriguchi M, Okada S, Hayashi Y, Nakayama H, Higaki T, Sugitani M. Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study. World J Surg 36(1): 144-150, 2012

つづきを見る

~2011

  1. Sunagawa K, Nishio H, Kinukawa N, Yamada T, Nemoto N, Ochiai T. An autopsy case of disseminated strongyloidiasis combined with cytomegalovirus infection. Jpn J Inf Dis 64(2): 150-152, 2011
  2. Takagi K, Takayama T, Nagase H, Moriguchi M, Wang X, Hirayamagi K, Suzuki T, Hasegawa H, Ochiai T, Yamaguchi N, Kochi M, Kimura M, Esumi M. High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma. Exp Ther Med 2(3): 425-431, 2011
  3. Yamada T, Sunagawa K, Homma T, Uehara K, Mizutani T, Kawabata Y. Ubiquitin-Positive Pneumocytes and Inclusion Bodies are Present in Secondary Organizing Pneumonia. Intern Med 50(4): 277-283, 2011
  4. Sugitani M, Nishimura S, Mizuno K, Shikata T. Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain. J Med Primatol 39: 1-8, 2010
  5. Ishibashi M, Wakita T, Esumi M. 2’-5’-oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Biochem Biophys Res Commun 392(3): 397-402, 2010
  6. Kudo I, Esumi M, Kida A, Ikeda M. p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma. Oncol Rep 24(4): 851-856, 2010

つづきを見る

PAGE TOP